被 發 現 含 有 未 標 示 西 藥 的 產 品
|
| |
| Australia: Safety advisory: Double Maxx D.B.M. Capsules contain the undeclared substance sildenafil (English Only) |
| |
The Therapeutic Goods Administration (TGA) has tested a product labelled Double Maxx D.B.M. Capsules and found that the capsules contain the undeclared substance sildenafil. Consumers are advised that sildenafil is a prescription-only medicine in Australia. Consumers are advised to stop taking the product and take any remaining capsules to their local pharmacy for safe disposal. If they have any concerns arising from their use of this product, consult their health care practitioner.
Please refer to the following website in TGA for details:
http://www.tga.gov.au/alert/double-maxx-dbm-capsules
In Hong Kong, the above product is not a registered pharmaceutical product.
Ends/Tuesday, Apr 23, 2019
Issued at HKT 16:00
|
| |
